BOCA RATON, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage biotechnology company targeting inflammation and immunology through the innate ...

"We're off to a solid start in 2025 on our mission to simplify the platform and upgrade our core Canadian apartment portfolio," commented Mark Kenney, President and Chief Executive Officer. "So far ...